GlassScriptPhysician profile
Rizwan Tai
NPI 1780039792
$1,921.29
in general payments reported to CMS, 2019-2025
15 companies · $267 in 2025
The $267 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,092 · 2021: $89.10 · 2022: $79.35 · 2023: $104 · 2024: $289 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medinc of Texas | $1,019.28 | 2020 | |
| Smith+Nephew, INC. | $276.64 | 2021-2025 | Grafix Pl, Renasys Touch, Stravix |
| Stryker Corporation | $223.72 | 2020-2025 | Prostep Mica, Augment Injectable |
| Paratek Pharmaceuticals, INC. | $77.63 | 2022-2025 | Nuzyra |
| Mimedx Group, INC. | $71.75 | 2024-2025 | |
| Biosense Webster, INC. | $67.90 | 2024 | Carto 3 |
| Integra Lifesciences Corporation | $34.06 | 2024-2025 | Integra |
| Zimmer Biomet Holdings, INC. | $29.39 | 2024 | Phoenix |
| Averitas Pharma INC. | $20.71 | 2025 | Qutenza |
| Lifenet Health | $20.36 | 2025 | Theragenesis Wound Matrix |
| Aroa Biosurgery Incorporated | $20.00 | 2023 | |
| Kerecis Limited | $17.17 | 2021 | |
| Medtronic, INC. | $15.18 | 2023 | Venaseal |
| Depuy Synthes Sales INC. | $14.15 | 2020 | |
| Amgen INC. | $13.35 | 2024 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rizwan Tai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.